Drug Maker Says PHI, Research, Confidential Business Data Potentially Stolen. Pharmaceutical maker Amgen has notified the U.S. Securities and Exchange Commission that cybercriminals have potentially stolen a cache of sensitive company data, including patient information, intellectual property, research and development, and other confidential business files.
First seen on govinfosecurity.com
Jump to article: www.govinfosecurity.com/amgen-tells-sec-hack-exposed-patient-data-trade-secrets-a-32401
